Expertise in
4
conditions

Christine Decanter

Lille, FR 
Expertise in
4
conditions
Lille, FR 

Overview

Christine Decanter practices practicing medicine in Lille, France.

Ms. Decanter is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Infertility, Ovarian Cysts, Amenorrhea, Polycystic Ovary Syndrome, and Oophorectomy.

She is actively involved in clinical research, co-authoring 64 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Lille, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation (CHACRY-1501)
Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation (CHACRY-1501)
Enrollment Status: Active_not_recruiting
Publish Date: March 18, 2026
Intervention Type: Procedure
Study Phase: Not Applicable
A Multicenter Prospective coHort Study of Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)
A Multicenter Prospective coHort Study of Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)
Enrollment Status: Terminated
Publish Date: January 31, 2025
Intervention Type: Drug, Other
Study Drug: Letrozole
Study Phase: Phase 4
Bisphenol A Exposure, Ovarian Function and Assisted Reproductive Technology Outcome.
Bisphenol A Exposure, Ovarian Function and Assisted Reproductive Technology Outcome.
Enrollment Status: Terminated
Publish Date: July 15, 2019
Intervention Type: Other
Study Phase: Not Applicable
View 2 Less Clinical Trials

64 Total Publications

Pre-treatment AMH levels suggesting PCOM do not prevent chemotherapy-induced ovarian damage despite higher long-term ovarian reserve: a longitudinal study in 467 women treated with alkylating agents.
Pre-treatment AMH levels suggesting PCOM do not prevent chemotherapy-induced ovarian damage despite higher long-term ovarian reserve: a longitudinal study in 467 women treated with alkylating agents.
Journal: Human reproduction (Oxford, England)
Published: April 01, 2026

Frequently Asked Questions about Christine Decanter

Is Christine Decanter a top-rated expert for Infertility?

MediFind is an objective health platform that identifies experts based on real-world data. Christine Decanter is classified as an Advanced expert for Infertility, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christine Decanter participate in research or clinical trials?

Yes. Christine Decanter has published 64 articles and abstracts on conditions like Infertility. You can view a list of Christine Decanter's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Decanter's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile